Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon L Goodman

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
New Biotechnology|January 23, 2018
The antibody horror show: an introductory guide for the perplexedSimon L Goodman
Nature|September 29, 2006
Piltdown wasn't cricket but does the hobbit ring true?Simon L Goodman
Journal of Cell Science|May 17, 2018
The path to VICTORy - a beginner's guide to success using commercial research antibodiesSimon L Goodman
F1000Research|January 17, 2019
The 3rd Antibody Validation meeting: Bath UK 20-21 <sup>st</sup> September 2018Simon L Goodman
Trends in Pharmacological Sciences|May 29, 2012
Integrins as therapeutic targetsSimon L Goodman, Martin Picard
Biology Open|December 6, 2012
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumorsSimon L Goodman, Hans Juergen Grote, Claudia Wilm
Current Opinion in Cell Biology|October 12, 2007
Structure and mechanics of integrin-based cell adhesionM Amin Arnaout, Simon L Goodman, Jian-Ping Xiong
Methods in Enzymology|August 19, 2007
Purification, analysis, and crystal structure of integrinsJian-Ping Xiong, Simon L Goodman, M Amin Arnaout
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 29, 2003
Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligationGeorgette Thumshirn, Ulrich Hersel, Simon L Goodman, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 5, 2013
Validation and comparison of anti-αvβ3 and anti-αvβ5 rabbit monoclonal versus murine monoclonal antibodies in four different tumor entitiesChristine Böger, Holger Kalthoff, Simon L Goodman, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
New Biotechnology|January 23, 2018
The antibody horror show: an introductory guide for the perplexedSimon L Goodman
Nature|September 29, 2006
Piltdown wasn't cricket but does the hobbit ring true?Simon L Goodman
Journal of Cell Science|May 17, 2018
The path to VICTORy - a beginner's guide to success using commercial research antibodiesSimon L Goodman
F1000Research|January 17, 2019
The 3rd Antibody Validation meeting: Bath UK 20-21 <sup>st</sup> September 2018Simon L Goodman
Trends in Pharmacological Sciences|May 29, 2012
Integrins as therapeutic targetsSimon L Goodman, Martin Picard
Biology Open|December 6, 2012
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumorsSimon L Goodman, Hans Juergen Grote, Claudia Wilm
Current Opinion in Cell Biology|October 12, 2007
Structure and mechanics of integrin-based cell adhesionM Amin Arnaout, Simon L Goodman, Jian-Ping Xiong
Methods in Enzymology|August 19, 2007
Purification, analysis, and crystal structure of integrinsJian-Ping Xiong, Simon L Goodman, M Amin Arnaout
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 29, 2003
Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligationGeorgette Thumshirn, Ulrich Hersel, Simon L Goodman, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 5, 2013
Validation and comparison of anti-αvβ3 and anti-αvβ5 rabbit monoclonal versus murine monoclonal antibodies in four different tumor entitiesChristine Böger, Holger Kalthoff, Simon L Goodman, et al.
Pageof 5